Chemomab Therapeutics (CMMB) Tops Q3 EPS by 15c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. TSCO
9. BE
10. SPY

Go back to Chemomab Therapeutics (CMMB) Tops Q3 EPS by 15c

Chemomab Therapeutics Announces Third Quarter 2022 Financial Results and Provides Corporate Update

November 11, 2022 6:00 AM EST

 Chemomab to Host Conference Call for Investors Today, November 11 at 8:00 am ET

TEL AVIV, Israel, Nov. 11, 2022 /PRNewswire/ -- Chemomab Therapeutics, Ltd. (Nasdaq: CMMB), a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for fibrotic and inflammatory diseases with high unmet need, today announced financial and operating results for the third quarter ended September 30, 2022 and provided a corporate update.

... More